Clinical characteristics of nursing home residents
| . | ADA/study goal . | Percent meeting goal (%) . |
|---|---|---|
| Glucose goal | Fasting (80–120 mg/dl) | 38 |
| Postprandial (100–140 mg/dl) | ||
| A1C | <7% | 67 |
| Blood pressure | <140/90 mmHg | 55 |
| ACE inhibitor/angiotensin receptor blocker | — | 52 |
| Lipids | Yearly | 31 |
| Electrocardiogram | Yearly | 37 |
| Microalbumin | Yearly | 7 |
| Aspirin | 75–325 mg | 42 |
| Foot exam | Monthly | 87 |
| Podiatrist consult | — | 58 |
| Eye exam | Yearly | 42 |
| Influenza vaccine | Yearly | 89 |
| Pneumoccocal vaccine | One lifetime | 46 |
| . | ADA/study goal . | Percent meeting goal (%) . |
|---|---|---|
| Glucose goal | Fasting (80–120 mg/dl) | 38 |
| Postprandial (100–140 mg/dl) | ||
| A1C | <7% | 67 |
| Blood pressure | <140/90 mmHg | 55 |
| ACE inhibitor/angiotensin receptor blocker | — | 52 |
| Lipids | Yearly | 31 |
| Electrocardiogram | Yearly | 37 |
| Microalbumin | Yearly | 7 |
| Aspirin | 75–325 mg | 42 |
| Foot exam | Monthly | 87 |
| Podiatrist consult | — | 58 |
| Eye exam | Yearly | 42 |
| Influenza vaccine | Yearly | 89 |
| Pneumoccocal vaccine | One lifetime | 46 |